Antimycobacterial Agents

Mycobacterium Tuberculosis

  • In patients < 35, with suspected exposure to TB with positive PPD and no clinical symptoms

Ø  Isoniazid – 6-9 months

  • In patients with a positive X-Ray, &/or positive smear of TB give 1st line agents

Ø  Isoniazid – 6 months – inhibits cell wall synthesis

Ø  Rifampin – 6 months – inhibits RNA polymerase

Ø  Pyrazinamide – at least 2 months

Ø  Ethambutol – for resistant strains

  • Treatment of resistant strains of TB – use 2nd line agents in addition to at least 2 first line agents to which the organism is susceptible

Ø  Ethionamide, Ciprofloxacin, Ofloxacin, Capreomycin, PAS

  • IF PREGNANT

Ø  Use: INH, RIF, EMB, pyridoxine

Ø  Don’t use – Pyrazinamide, Ags, Quinolones, Ethionamide

  • If contracts TB meningitis

Ø  use Pyrazinamide (75-100% CNS penetration), Ethionamide (100%), INH (20-100%)

Mycobacterium Avium-intracellulare complete (MAC)

  • occurs predominantly in AIDS patients
  • No known effective therapy
  • Try to use:

Ø  Amikacin, Ciprofloxacin, Clarithromycin (prophylaxis), Rifabutin, Ethambutol

M. fortuitum, M. chelonae

  • rapid growers
  • usually cause of chronic wound infections
  • use: Amikacin, Cephalosporins, Imipenem

First Line Anti-TB drugs – INH, Rifampin, Rifabutin, Ethambutol, Streptomycin, Pyrazinamide

Isoniazid

  • inhibits cell wall synthesis
  • most active anti-TB agent; penetrates the CSF well
  • Bactericidal for TB
  • Side effect – hepatitis
  • There are slow and rapid acetylators
  • Drug interactions

Ø  Phenytoin – inhibits the parahydroxylation – monitor for toxicity

  • Add Vit B-6 (Pyridoxine) to regimen

Rifampin, Rifabutin

  • inhibit bacterial RNA polymerase
  • bactericidal for intracellular and extracellular TB
  • Rifabutin effective against MAC – 30% of strains resistant to rifampin are susceptible to rifabutin
  • ORANGE COLOR TO SECRETIONS
  • Drug interactions

-        decreases t1/2 of prednisone, digitoxin, ketoconazole, propranolol

-        decreases the effectiveness of oral contraceptives

  • Contraindications: HIV patients

Ethambutol

  • Inhibits Mycobacterial arabinosyl transferases encoded by cmb-CAB operon, therefore esssential arabinoglycan can’t be produced for the cell wall
  • Bacteriostatic
  • Poor CSF penetration
  • Side effect: visual disturbances
  • Inhibits cell wall synthesis

Streptomycin (aminoglycoside)

  • bactericidal for TB
  • has to be given IM
  • ototoxicity and nephrotoxicity
  • among other aminoglycosides, Amikacin more effective against MAC and rapid growers

Pyrazinamide

  • Unknown mechanism, but does its killing inside of macrophages
  • Bactericidal for TB at acidic pH (within MACS)
  • Good CSF penetration

2nd Line Anti-TB Drugs – Ethionamide, PAS, Quinolones

Ethionamide

  • blocks synthesis of mycolic acids
  • not commonly used
  • good CSF penetration

Para-Aminosalicylic Acid

  • Bacteriostatic
  • Inhibits folic acid synthesis in mycobacteria
  • not often used

Quinolones – Ciprofloxacin, Ofloxacin

  • some activity against TB and MAC and fortuitum
  • concentrate in lung

Other Antimycobacterial Agents – Dapsone, Clofazimine

Dapsone

  • related to sulfas
  • used in combo with Rifampin & Clofazimine for treatment of M. leprae
  • 2 years of treatment

Clofazimine

  • bactericidal against M. leprae
  • also acts in an anti-inflammatory manner to prevent the erythema nodosum leprosum
  • also has a little activity against M. ulcerans and MAC
  • RED discoloration of the skin may develop.

Tags: , , , , , , , , , ,